B. Gaugler et D. Olive, Tumors antigens recognized by T-cells in human cancers. New advances and therapeutic perspectives., PATH BIOL, 46(10), 1998, pp. 771-778
The melanoma antigen coded by the MAGE-1 gene was the first tumor antigen d
escribed in human cancer. Genetic, biochemical, and "candidate peptide" str
ategies have been used to identify antigenic peptides presented to T-cells
by class I major histocompatibility complex antigens. Antigens have now bee
n characterized in a wide variety of tumor types. Five categories have been
described based on expression profile. These antigens are detailed in this
review. Among the tumor antigens produced as a result of intratumoral muta
tions, some are of special interest because of their potentially oncogenic
effects. These new data can be expected to lead to the development of novel
anticancer treatments based on specific immunotherapy. Pilot clinical stud
ies are ongoing.